Presence of a potent transcription activating sequence in the p53 protein.
暂无分享,去创建一个
[1] D. Lane,et al. T antigen is bound to a host protein in SY40-transformed cells , 1979, Nature.
[2] P. Goodfellow,et al. Detection of a common feature in several human tumor cell lines--a 53,000-dalton protein. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[3] G. Khoury,et al. p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Levine,et al. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells , 1982, Cell.
[5] D. Lane,et al. Cellular proteins involved in SV40 transformation , 1983 .
[6] V. Rotter,et al. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation , 1984, Nature.
[7] J. Jenkins,et al. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53 , 1984, Nature.
[8] P. Gruss,et al. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells , 1984, Nature.
[9] C. Yanisch-Perron,et al. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. , 1985, Gene.
[10] K. Struhl,et al. Functional dissection of a eukaryotic transcriptional activator protein, GCN4 of Yeast , 1986, Cell.
[11] M. Ptashne,et al. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. , 1986, Science.
[12] M. Horowitz,et al. The long terminal repeat of the intracisternal A particle as a target for transactivation by oncogene products , 1986, Journal of virology.
[13] R. Carroll,et al. Mapping of phosphomonoester and apparent phosphodiester bonds of the oncogene product p53 from simian virus 40-transformed 3T3 cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Levine,et al. Identification of the p53 protein domain involved in formation of the simian virus 40 large T-antigen-p53 protein complex , 1986, Journal of virology.
[15] E. Moran,et al. Multiple functional domains in the adenovirus E1A gene , 1987, Cell.
[16] Mark Ptashne,et al. Mutants of GAL4 protein altered in an activation function , 1987, Cell.
[17] Jun Ma,et al. Deletion analysis of GAL4 defines two transcriptional activating segments , 1987, Cell.
[18] Jun Ma,et al. A new class of yeast transcriptional activators , 1987, Cell.
[19] Mark Ptashne,et al. Negative effect of the transcriptional activator GAL4 , 1988, Nature.
[20] Jun Ma,et al. GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.
[21] F. Collins,et al. Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.
[22] A. Levine,et al. The p53 proto-oncogene can act as a suppressor of transformation , 1989, Cell.
[23] Michael R. Green,et al. Transcription activation by the adenovirus E1a protein , 1989, Nature.
[24] S. Fields,et al. A novel genetic system to detect proteinprotein interactions , 1989, Nature.
[25] M. Oren,et al. Wild-type p53 can inhibit oncogene-mediated focus formation. , 1989, Proceedings of the National Academy of Sciences of the United States of America.